Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is -404.58%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -33.45%.
RETURN ON ASSETS (ROA)
-404.58%
RETURN ON ASSETS (ROA) AVG TTM
N/A
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
-1342.61%
vs the sector median at left
Caring Brands, Inc.
Market Cap
$10.55M
Return on Assets (ROA)
-404.58%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.55M
Return on Assets (ROA)
-88.09%
TTM Avg
-90.94%
3Y Avg
-60.82%
5Y Avg
-50.49%
Market Cap
$10.42M
Return on Assets (ROA)
-204.84%
TTM Avg
-224.84%
3Y Avg
-332.29%
5Y Avg
-789.37%
Market Cap
$10.91M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$10.83M
Return on Assets (ROA)
N/A
TTM Avg
-37.02%
3Y Avg
-41.41%
5Y Avg
-41.74%
Market Cap
$10.61M
Return on Assets (ROA)
-77.94%
TTM Avg
-178.68%
3Y Avg
-1009.31%
5Y Avg
-2782.57%
Market Cap
$11.12M
Return on Assets (ROA)
-154.89%
TTM Avg
-40.68%
3Y Avg
-87.98%
5Y Avg
-439.28%
Market Cap
$11.11M
Return on Assets (ROA)
-26.45%
TTM Avg
-58.62%
3Y Avg
-47.64%
5Y Avg
-51.16%
Market Cap
$11.23M
Return on Assets (ROA)
-46.21%
TTM Avg
-17.41%
3Y Avg
-49.70%
5Y Avg
-52.01%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $10.55M | -404.58% | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | -88.09% | -90.94% | -60.82% | -50.49% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.42M | -204.84% | -224.84% | -332.29% | -789.37% |
| Cerenome, Inc. (CNSY)vs › | $10.91M | -185.94% | -166.39% | -133.67% | -110.62% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.83M | N/A | -37.02% | -41.41% | -41.74% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.61M | -77.94% | -178.68% | -1009.31% | -2782.57% |
| BioVie Inc. (BIVI)vs › | $11.12M | -154.89% | -40.68% | -87.98% | -439.28% |
| Biofrontera Inc. (BFRI)vs › | $11.11M | -26.45% | -58.62% | -47.64% | -51.16% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.23M | -46.21% | -17.41% | -49.70% | -52.01% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | -132.59% | -75.28% | -65.73% | -52.31% |
ROA
-404.6%
ROE
-506.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -269.82% |
